The UK has introduced an anti-CGRP single anti-Ajovy pre-filled pen for migraines: patients can inject themselves.

Teva UK has launched Ajovy's pre-filled pen in the UK, providing migraine sufferers with a more convenient and flexible way to do it than syringes and can manage it at home.
Ajovy is an all-human monoclonal antibody that targets calcitonin gene-related peptides (CGRP) to prevent migraines at least four times a month in adults.
: The drug is the first and only anti-CGRP drug recommended by the NHS for patients with chronic migraines.
new Ajovy pre-fill pen developed in the UK, including buttonless, push-down, audible signals, instructions for management progress, and windows showing dose delivery.
can be injected into areas of the abdomen, thighs, or upper arm that do not have bruises, redness, or hard knots.
Mark Weatherall, chairman of the British Headache Research Association, said: "Migraines are a debilitating neurological condition that, if left untreated, can strike at any time and make patients feel helpless.
"Fremanezumab is effective and well-um-resistant and is particularly useful for complex migraine patients who are not available for other treatments.
pre-filled pen is easy to self-manage and enhances patients' control over their condition.
.